We are recruiting qualified postdoctoral candidates to engage in one of several different lines of HIV-related research. Our group seeks to translate basic research findings to develop model systems that more faithfully mimic HIV infection in vivo. These model systems are used to investigate questions on viral transmission, viral pathogenesis, and the contribution of the host immune system in these processes. An important part of this effort includes the use of animal models to study HIV antiviral resistance and immunopathogenesis, studies to uncover cellular factors that assist or interfere with the virus lifecycle, and an examination of the mechanism of HIV transmission by dendritic cells. We believe this multidisciplinary approach is not only intellectually stimulating but enhances the rigor and breadth by which we can attack scientific problems.

Highly motivated candidates with a fundamental training in cell biology, genetics, immunology, molecular biology, or virology are encouraged to apply. Candidates should have a Ph.D. and/or an M.D. and have less than 5 years of postdoctoral experience. To apply, candidates should click on the button below or send an e-mail to vineet.kewalramani@nih.gov with a cover letter, CV, and the names and contact information for 3 references.

Vineet N. KewalRamani, Ph.D.
Model Development Section
HIV Drug Resistance Program, National Cancer Institute
NCI-Frederick, P.O. Box B
Building 535, Room 108C
Frederick, MD 21702-1201

E-mail: vineet.kewalramani@nih.gov
Web site: http://home.ncifcrf.gov/hivdrp/KewalRamani.html


This position is subject to a background investigation.


The NIH is dedicated to building a diverse community in its training and employment programs.

To apply:

The National Cancer Institute coordinates the National Cancer Program, which conducts and supports research, training, health information dissemination, and other programs with respect to the cause, diagnosis, prevention, and treatment of cancer, rehabilitation from cancer, and the continuing care of cancer patients and the families of cancer patients. Specifically, the Institute:

• Supports and coordinates research projects conducted by universities, hospitals, research foundations, and businesses throughout this country and abroad through research grants and cooperative agreements.
• Conducts research in its own laboratories and clinics.
• Supports education and training in fundamental sciences and clinical disciplines for participation in basic and clinical research programs and treatment programs relating to cancer through career awards, training grants, and fellowships.
• Supports research projects in cancer control.
• Supports a national network of cancer centers.
• Collaborates with voluntary organizations and other national and foreign institutions engaged in cancer research and training activities.
• Encourages and coordinates cancer research by industrial concerns where such concerns evidence a particular capability for programmatic research.
• Collects and disseminates information on cancer.
• Supports construction of laboratories, clinics, and related facilities necessary for cancer research through the award of construction grants.